{"ok":true,"trend":{"id":265221,"platform":"news","region":"global","key":"phase iii success pushes kodiak’s eye treatment towards approval","title":"Phase III Success Pushes Kodiak’s Eye Treatment Towards Approval","url":"https://news.google.com/rss/articles/CBMiwgFBVV95cUxQSkZfOFlFbEhoNGxOam56amZUMnpRbTNwNGlLUkFhN1B3cjJiN1JNWXFhS2RUYVJFZHlTVUdMTVdCWWpQVS1jQkl1ZjRvTHY3TnB6RlhFdkFHN2U5Mld3emY0OXVNZ1VXcnV6YUs5OUVKXzRYeHVHMXUzNzFvWC1uSVh4Vk9Id2xnamhnZEU5WGZFOElIclFxb0tDbHcwTkMzMHJnUWt2Rl9iUXBVZEFzMy00eFJuS2UtWDhEZkYxSnZWZw?oc=5","first_seen":"2026-09-28T18:48:55.179259Z","last_seen":"2026-09-28T21:32:53.398855Z","last_rank":32,"peak_rank":20,"last_volume":null,"peak_volume":0,"seen_count":3,"score":0.7434375,"category_hint":"medicine","section":"health","category":"medicine","summary":"Kodiak Sciences reports that its experimental eye treatment has succeeded in a Phase III clinical trial, moving the therapy a step closer to regulatory approval. The positive late-stage results put the biotech company on track to file for authorization, offering a potential new option for patients with retinal disease. Details on the specific condition treated and the data were not provided.","why":"A successful Phase III trial is a major milestone that typically triggers approval filings and market interest.","tone":"positive","entities":["Kodiak Sciences"],"summarized_at":"2026-09-28T18:50:00.841284Z","meta":{"via":"scan","lang":"en","term":"medicine","source":"Inside Precision Medicine","generic":0.03,"published":"Mon, 28 Sep 2026 18:33:14 GMT"},"nw":0.54,"promo":0.03,"kind":"news_event","importance":1.47,"hidden":false,"hide_reason":null,"judged_at":"2026-09-28T18:48:56.541510Z","title_en":"Kodiak Sciences' Eye Treatment Succeeds in Phase III Trial","section_name":"Health","category_name":"Medicine","timeline":[{"captured_at":"2026-09-28T18:48:55.179259Z","rank":20,"volume":null},{"captured_at":"2026-09-28T20:10:56.932766Z","rank":27,"volume":null},{"captured_at":"2026-09-28T21:32:53.398855Z","rank":32,"volume":null}],"posts":[{"platform":"news","url":"https://news.google.com/rss/articles/CBMiwgFBVV95cUxQSkZfOFlFbEhoNGxOam56amZUMnpRbTNwNGlLUkFhN1B3cjJiN1JNWXFhS2RUYVJFZHlTVUdMTVdCWWpQVS1jQkl1ZjRvTHY3TnB6RlhFdkFHN2U5Mld3emY0OXVNZ1VXcnV6YUs5OUVKXzRYeHVHMXUzNzFvWC1uSVh4Vk9Id2xnamhnZEU5WGZFOElIclFxb0tDbHcwTkMzMHJnUWt2Rl9iUXBVZEFzMy00eFJuS2UtWDhEZkYxSnZWZw?oc=5","author":"Inside Precision Medicine","title":"Phase III Success Pushes Kodiak’s Eye Treatment Towards Approval","snippet":null,"posted_at":"2026-09-28T18:33:14Z","likes":null}],"elsewhere":[],"window":"7d"}}